Allstate insider sells 33,986 shares after exercises
Allstate Corporation insider Jesse E. Merten reported a combination of equity awards exercises and stock sales.
Rhea-AI Filing Summary
Allstate Corporation insider Jesse E. Merten reported a combination of equity awards exercises and stock sales. On February 24–25, 2026, he acquired Allstate common shares by exercising employee stock options and converting restricted stock units, then sold 33,986 common shares in open-market transactions executed under a Rule 10b5-1 trading plan adopted on November 7, 2025.
The reported sale prices were weighted averages between $206.96 and $210.47 per share across several price brackets. After these transactions, he directly owned 32,301 Allstate common shares and indirectly held 7,823 shares through a 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 12,879 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (Right to Buy) | 1,734 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (Right to Buy) | 19,373 | $0.00 | $0.00 |
| Exercise | Common Stock | 12,879 | $122.64 | $1.58M |
| Exercise | Common Stock | 1,734 | $133.00 | $231K |
| Exercise | Common Stock | 19,373 | $137.10 | $2.66M |
| Sale | Common Stock | 8,811 | $207.5314 | $1.83M |
| Sale | Common Stock | 15,893 | $208.5753 | $3.31M |
| Sale | Common Stock | 7,982 | $209.4048 | $1.67M |
| Sale | Common Stock | 1,300 | $210.4385 | $274K |
| Exercise | Restricted Stock Units | 1,201 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,201 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 533 | $209.82 | $112K |
| holding | Common Stock | -- | -- | -- |
Footnotes (6)
- F1. Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 24, 2027 and February 24, 2028.
- F2. The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025.
- F3. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $206.96 to $207.86. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- F4. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $207.96 to $208.95. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- F5. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $208.97 to $209.96. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- F6. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $210.06 to $210.47. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
FAQ
What did Allstate (ALL) insider Jesse E. Merten report in this Form 4?
Were Jesse E. Merten’s Allstate (ALL) stock sales under a 10b5-1 trading plan?
What role do restricted stock units and options play in this Allstate (ALL) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.